Overview


Ranitidine is an over-the-counter (OTC) and prescription histamine type 2 receptor blocker. Ranitidine is used to treat ulcers in the intestines and stomach, gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. In stomach ulcers or peptide ulcers, open sores appear on the inner lining of the stomach and upper portion of the small intestine. By reducing excess acid production in the stomach, ranitidine is helpful in treating patients with acid reflux. A growing number of risk factors are increasing the risk of developing peptide ulcers in patients, including pain relievers, certain medications (steroids, low-dose aspirin, combinations of selective serotonin reuptake inhibitors with pain relievers), smoking, excessive alcohol consumption, untreated stress, and eating spicy foods; ulcer risk is significantly increased. When given by injection, headaches and pain or burning are common side effects. Among the serious side effects are liver problems, a slow heart rate, pneumonia, and the possibility of masking stomach cancer. There is also an increased risk of Clostridium difficile colitis associated with it. An antagonist of the H2 histamine receptor, ranitidine decreases stomach acid production by blocking histamine. There is a possibility that ranitidine may increase your risk of developing pneumonia. A coughing up green or yellow mucus is one of the symptoms of pneumonia. Chest pain, fever, feeling short of breath, and shortness of breath are other symptoms. You should discuss your specific risk of pneumonia with your doctor. Ranitidine allergies should not be treated with this medication. Ranitidine granules and effervescent tablets must be dissolved in water before taking them. It is possible that your doctor will recommend an antacid to relieve pain. Follow your doctor's instructions regarding the type of antacid to take, and when to take it. Drinking alcohol should be avoided. You are more likely to suffer stomach damage if you take this medication. You may need to use this medicine for up to eight weeks before your ulcer heals. Keep taking the medication as directed for best results. Your symptoms may not improve after six weeks of treatment, so talk to your doctor. Products and companies involved in research and development, production, and distribution of generic, non-generic, and veterinary drugs make up the global pharmaceuticals market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Ranitidine Hydrochloride Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Ranitidine Hydrochloride Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • GlaxoSmithKline Plc
  • Boehringer ingelheim GmbH
  • Strides Pharma Science limited
  • Tocris Bioscience
  • Merck KGaA
  • Sun Pharmaceuticals

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Drug Class

  • Oral
  • Intravenous

By Application

  • Intestinal and Stomach Ulcers
  • Zollinger -Ellison Syndrome
  • Gastroesophageal Reflux Disease (GERD)
  • Esophagitis
  • Other Application

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Ranitidine Hydrochloride Market By Drug Class, By Application, By Distribution Channel and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Ranitidine Hydrochloride Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Ranitidine Hydrochloride Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Ranitidine Hydrochloride Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Ranitidine Hydrochloride Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Intravenous

  • 8.   Ranitidine Hydrochloride Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Intestinal and Stomach Ulcers
        2. Zollinger -Ellison Syndrome
        3. Gastroesophageal Reflux Disease (GERD)
        4. Esophagitis
        5. Other Application

  • 9.   Ranitidine Hydrochloride Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Online Pharmacies

  • 10.   North America Ranitidine Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Ranitidine Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Ranitidine Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Ranitidine Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Ranitidine Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GlaxoSmithKline Plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boehringer ingelheim GmbH
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Strides Pharma Science limited
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Tocris Bioscience
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Merck KGaA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Sun Pharmaceuticals
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients